Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies - Takeaways - MDSpire

Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies

  • By

  • Clark Zheng

  • Kelsey Muir

  • Himanshu Kaushik

  • Keertana Yalamanchili

  • Keyana Zahiri

  • Adam Yeo

  • Justin Kim

  • Frank W. Sellke

  • June 5, 2026

  • 0 min

Share

  • 1

    Cardiopulmonary bypass (CPB) disrupts microcirculation, leading to tissue hypoxia despite normal systemic hemodynamics.

  • 2

    Endothelial dysfunction and glycocalyx shedding during CPB are significant contributors to microvascular impairment.

  • 3

    Current microcirculatory assessment tools face technical challenges and lack standardized endpoints for clinical use.

  • 4

    Cardioprotective strategies during CPB include mechanical approaches, ischemic preconditioning, and pharmacologic interventions.

  • 5

    Translating findings from experimental models to clinical practice remains challenging, highlighting the need for better integration of imaging and biomarkers.

Original Source(s)

Related Content